5613294 BASELINE PATIENT CHARACTERISTICS FROM A UK EARLY ACCESS TO MEDICINES SCHEME (EAMS) WITH VOXELOTOR, A HBS POLYMERIZATION INHIBITOR, FOR THE TREATMENT OF HEMOLYTIC ANEMIA DUE TO SICKLE CELL DISEASE

• P. Eleftheriou,
• J. Sharif,
• R. Kesse-Adu,
• M. Filian-Gloor,
• A. Agrawal,
• G. Barcelos,
• P. Telfer

Affiliations

P. Eleftheriou

J. Sharif

R. Kesse-Adu

M. Filian-Gloor

A. Agrawal

G. Barcelos

P. Telfer